A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR

Immunity

Volumn 8, Issue 5, 1998, Pages 543-552

  Daniel, Claude ^a,b   Horvath, Stephen ^a   Allen, Paul M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ALLOANTIGEN IE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; HYBRIDOMA; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032076237     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80559-2     Document Type: Article

References (66)

1. Allen, P.M. (1987). Construction of murine T-T hybridomas. In Monoclonal Antibody Production Techniques and Applications, L.B. Schook, ed. (New York: Marcel Dekker), pp. 25-34.
2. Ausubel, L.J., Kwan, C.K., Sette, A., Kuchroo, V., and Hafler, D.A. (1996). Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones. Proc. Natl. Acad. Sci. USA 93, 15317-15322.
3. Ausubel, L.J., Krieger, J.I., and Hafler, D.A. (1997). Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99. J. Immunol. 159, 2502-2512.
4. bm12-reactive T cells. J. Exp. Med. 169, 115-133.
5. Blake, J., Johnston, J.V., Hellström, K.E., Marquardt, H., and Chen, L. (1996). Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes. J. Exp. Med. 184, 121-130.
6. Bluestone, J.A., Jameson, S., Miller, S., and Dick, R. II (1992). Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. J. Exp. Med. 176, 1757-1761.
7. Braunstein, N.S., Germain, R.N., Loney, K., and Berkowitz, N. (1990). Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules: implications for la function and evolution. J. Immunol. 145, 1635-1645.
8. Brock, R., Wiesmüller, K.-H., Jung, G., and Walden, P. (1996). Molecular basis for t he recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. Proc. Natl. Acad. Sci. USA 93, 13108-13113.
9. Burrows, S.R., Silins, S.L., Khanna, R., Burrows, J.M., Rischmueller, M., McCluskey, J., and Moss, D.J. (1997). Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by Tcells and its role in allore-activity. Eur. J. Immunol. 27, 1726-1736.
10. Carson, R.T., Vignali, K.M., Woodland, D.L., and Vignali, D.A.A. (1997). T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 7, 387-399.
11. Catipovic, B., Dal Porto, J., Mage, M., Johansen, T.E., and Schneck, J.P. (1992). Major histocompatibility complex conformational epitopes are peptide specific. J. Exp. Med. 176, 1611-1618.
12. Chattopadhyay, S.K., Theobald, M., Biggs, J., and Sherman, L.A. (1994). Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity. J. Exp. Med. 179, 213-219.
13. Chothia, C., Boswell, D.R., and Lesk, A.M. (1988). The outline structure of the T-cell αβ receptor. EMBO J. 7, 3745-3755.
14. Coppin, H.L., Carmichael, P., Lombardi, G., L'Faqihi, F.E., Salter, R., Parham, P., Lechler, R.I., and De Preval, C. (1993). Position 71 in the α helix of the DRb domain is predicted to influence peptide binding and plays a central role in allorecognition. Eur. J. Immunol. 23, 343-349.
15. Crumpacker, D.B., Alexander, J., Cresswell, P., and Engelhard, V.H. (1992). Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2. J. Immunol. 148, 3004-3011.
16. Daniel, C., Grakoui, A., and Allen, P.M. (1998). Inhibition of a MHC class II specific T cell alloresponse using altered peptide ligands. J. Immunol., 160, 3244-3250.
17. k molecule fortuitously provokes an alloresponse. Eur. J. Immunol. 21, 209-213.
18. Evavold, B.D., Williams, S.G., Hsu, B.L., Buus, S., and Allen, P.M. (1992). Complete dissection of the Hb(64-76)determinant using Th1, Th2 clones, and T cell hybridomas. J. Immunol. 148, 347-353.
19. Evavold, B.D., Sloan-Lancaster, J., and Allen, P.M. (1994). Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand. Proc. Natl. Acad. Sci. USA 91, 2300-2304.
20. Evavold, B.D., Sloan-Lancaster, J., Wilson, K.J., Rothbard, J.B., and Allen, P.M. (1995). Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2, 655-663.
21. Fink, P.J., Matis, L.A., McElligott, D.L., Bookman, M., and Hedrick, S.M. (1986). Correlations between T-cell specificity and the structure of the antigen receptor. Nature 321, 219-226.
22. Frelinger, J.A., and McMillan, M. (1996). The role of peptide specificity in MHC class I-restricted allogeneic responses, Immunol. Rev. 154, 45-58.
23. Fremont, D.H., Hendrickson, W.A., Marrack, P., and Kappler, J. (1996). Structures of an MHC class II molecule with covalently bound single peptides. Science 272, 1001-1004.
24. Garboczi, D.N., Ghosh, P., Utz, U., Fan, Q.R., Biddison, W.E., and Wiley, D.C. (1996). Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384, 134-141.
25. Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson, M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. (1996). An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274, 209-219.
26. Grandea, A.G. III, and Bevan, M.J. (1992). Single-residue changes in class I major histocompatibility complex molecules stimulate responses to self peptides. Proc. Natl. Acad. Sci. USA 89, 2794-2798.
27. Hemmer, B., Fleckenstein, B.T., Vergelli, M., Jung, G., McFarland, H., Martin, R., and Wiesmüller, K.-H. (1997). Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185, 1651-1659.
28. Hong, S.-C., Sant'Angelo, D.B., Dittel, B.N., Medzhitov, R., Yoon, ST., Waterbury, P.G., and Janeway, C.A., Jr. (1997). The orientation of a T cell receptor to its MHC class II:peptide ligands. J. Immunol. 159, 4395-4402.
29. Hsu, B.L., Evavold, B.D., and Allen, P.M. (1995). Modulation of T cell development by an endogenous altered peptide ligand. J. Exp. Med. 181, 805-810.
30. k determinant: single conservative amino acid changes in the complementarity-determining region 3 dramatically alter antigen fine specificity. J. Immunol. 157, 2291-2298.
31. Ignatowicz, L., Kappler, J., and Marrack, P. (1996). The repertoire of T cells shaped by asingle MHC/peptide ligand. Cell 84, 521-529.
32. Janeway, C.A. Jr., and Travers, P. (1997). Antigen recognition by T lymphocytes. In Immunobiology: The Immune System In Health and Disease (New York: Current Biology/Garland Publishing).
33. Joyce, S., and Nathenson, S.G. (1996). Alloreactivity, antigen recognition and T-cell selection: three diverse T-cell recognition problems with a common solution, Immunol. Rev. 154, 59-103.
34. Kisielow, P., and von Boehmer, H. (1995). Development and selection of T cells: facts and puzzles. Adv. Immunol. 58, 87-209.
35. Kuzushima, K., Sun, R., Van Bleek, G.M., Vegh, Z., and Nathenson, S.G. (1995). The role of self peptides in the allogeneic cross-reactivity of CTLs. J. Immunol. 155, 594-601.
36. Loftus, D.J., Chen, Y., Covell, D.G., Engelhard, V.H., and Appella, E. (1997). Differential contact of disparate class I/peptide complexes as the basis for epitope cross-recognition by a single T cell receptor. J. Immunol. 158, 3651-3658.
37. Lombardi, G., Sidhu, S., Batchelor, J.R., and Lechler, R.I. (1989). Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides. Proc. Natl. Acad. Sci. USA 86, 4190-4194.
38. Lorenz, R.G., and Allen, P.M. (1988). Direct evidence for functional self protein/la-molecule complexes in vivo. Proc. Natl. Acad. Sci. USA 85, 5220-5223.
39. Malis, L.A., Sorger, S.B., McElligott, D.L., Fink, P.J., and Hedrick, S.M. (1987). The molecular basis of alloreactivity in antigen-specific, major histocompatibility complex-restricted T cell clones. Cell 51, 59-69.
40. Matzinger, P., and Bevan, M.J. (1977). Why do so many lymphocytes respond to major histocompatibility antigens? Cell, Immunol. 29, 1-5.
41. McHeyzer-Williams, M.G., and Davis, M.M. (1995). Antigen-specific development of primary and memory T cells in vivo. Science 268, 106-111.
42. bm12:a new H-2 mutation in the I region in the mouse. J. Exp. Med. 150, 1323-1328.
43. Miyazaki, T., Wolf, P., Tourne, S., Waltzinger, C., Dierich, A., Barois, N., Ploegh, H., Benoist, C., and Mathis, D. (1996). Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84, 531-541.
44. Panina-Bordignon, P., Corradin, G., Roosnek, E., Sette, A., and Lanzavecchia, A. (1991). Recognition by class II alloreactive T cells of processed determinants from human serum proteins. Science 252, 1548-1550.
45. Pease, L.R., Horton, R.M., Pullen, J.K., Hunt, H.D., Yun, T.J., Rohren, E.M., Prescott, J.L., Jobe, S.M., and Allen, K.S. (1993). Amino acid changes in the peptide binding site have structural consequences at the surface of class I glycoproteins. J. Immunol. 150, 3375-3381.
46. Penzotti, J.E., Doherty, D., Lybrand, T.P., and Nepom, G.T. (1996). A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis. J. Autoimmun. 9, 287-293.
47. Racioppi, L., Ronchese, F., Schwartz, R.H., and Germain, R.N. (1991). The molecular basis of class II MHC allelic control of T cell responses. J. Immunol. 147, 3718-3727.
48. Racioppi, L., Ronchese, F., Matis, L.A., and Germain, R.N. (1993). Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligandrelated differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177, 1047-1060.
49. Rammensee, H.-G., Friede, T., and Stevanovic, S. (1995). MHC ligands and peptide motifs: first listing, Immunogenetics 41, 178-228.
50. Rötzschke, O., Falk, K., Faath, S., and Rammensee, H.-G. (1991). On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174, 1059-1071.
51. Sant'Angelo, D.B., Waterbury, G., Preston-Hurlburt, P., Yoon, S.T., Medzhitov, R., Hong, S.-C., and Janeway, C.A., Jr. (1996). The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity 4, 367-376.
52. Schild, H., Grüneberg, U., Pougialis, G., Wallny, H.-J., Keilholz, W., Stevanovic, S., and Rammensee, H.-G. (1995). Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules. Int. Immunol. 7, 1957-1965.
53. d and the T cell receptor. J. Immunol. 157, 4478-4485.
54. Sherman, L.A and Chattopadhyay, S. (1993). The molecular basis of allorecognition. Annu. Rev. Immunol. 11, 385-402.
55. Sim, B.-C., Travers, P.J., and Gascoigne, N.R. J. (1997). Vα3.2 selection in MHC class Imutant mice: evidence for an alternate orientation of TCR-MHC class I interaction. J. Immunol. 159, 3322-3329.
56. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1994). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 360, 215-221.
57. b molecule. Immunity 3, 573-582.
58. Sykulev, Y., Brunmark, A., Tsomides, T.J., Kageyama, S., Jackson, M., Peterson, P.A., and Eisen, H.N. (1994). High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. USA 91, 11487-11491.
59. bm3 molecule. J. Ilmmunol. 155, 2419-2426.
60. Tallquist, M.D., Yun, T.J., and Pease, L.R. (1996). A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J. Exp. Med. 184, 1017-1026.
61. + cytotoxic T lymphocytes in association with a class IMHC protein. Cell 69, 989-998.
62. Vella, J.P., Spadafora-Ferreira, M., Murphy, B., Alexander, S.I., Harmon, W., Carpenter, C.B., and Sayegh, M.H. (1997). Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 64, 795-800.
63. Wang, W., Man, S., Gulden, P.H., Hunt, D.F., and Engelhard, V.H. (1998). Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. J. Immunol. 160, 1091-1097.
64. p haplotypes. Immunogenetics 44, 231-232.
65. Wen, R., Cole, G.A., Surman, S., Blackman, M.A., and Woodland, D.L. (1996). Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. J. Exp. Med. 183, 1083-1092.
66. Wettstein, D.A., Boniface, J.J., Reay, P.A., Schild, H., and Davis, M.M. (1991). Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J. Exp. Med. 174, 219-228.